IP Library Granted Patent US 9,851,345
Granted Patent B1
US 9,851,345 · App. 15/466,377 · Granted Dec 26, 2017

Compositions and methods for disease diagnosis using single cell analysis

Inventors: Nicolas Arab (Austin, TX); Ross Johnson (Austin, TX)
Assignee: VIASPHERE, LLC
G01N33/5091C12Q1/04C12Q1/18G01N21/6428G01N33/5011G01N33/582G01N2201/0621G01N2800/26
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,851,345
App. No.
15/466,377
Granted
Dec 26, 2017
Kind
B1
Abstract

Certain embodiments of the invention are directed to evaluating and identifying cells by recording and interpreting a time-dependent signal produced by unique cell respiration and permeability attributes of isolated viable cells.

Claims (22)

1. A method for detecting and characterizing microbes in a sample, the method comprising:

(a) contacting a sample containing microbes with at least one reporter forming a sample mixture, wherein optical emissions of the reporter indicate microbial cell viability;

(b) dividing the sample mixture into at least two portions, wherein a first portion is treated with an antimicrobial drug forming a test portion and the second portion is a control portion;

(c) partitioning the test portion and the control portion into two-dimensional arrays of sub-nanoliter droplets, wherein a portion of the droplets have one microbe or one natural microbe aggregate per droplet;

(d) incubating the sub-nanoliter droplets for a period of time at a specified temperature or series of temperatures;

(e) monitoring optical emissions of the sub-nanoliter droplets during the incubation time;

(f) constructing an optical emission waveform for each sub-nanoliter droplet based on the optical emissions of the sub-nanoliter droplet over time resulting in a sub-nanoliter droplet waveform;

(g) identifying the microbes in the sample using the sub-nanoliter droplet waveforms; and

(h) determining susceptibility of the microbes in the sample to the antimicrobial drug by comparing waveforms for sub-nanoliter droplets of the treated portion to waveforms of the sub-nanoliter droplets of the control portion, wherein differences in the sub-nanoliter droplet waveforms between the droplets of the treated portion to droplets of the control portion indicates susceptibility to the antimicrobial.

2. The method of claim 1 , wherein the sub-nanoliter droplets are formed in an immiscible fluid.

3. The method of claim 2 , wherein the immiscible fluid is a fluorocarbon comprising a fluorosurfactant.

4. The method of claim 1 , wherein partitioning of the sample into sub-nanoliter droplets is done by Laplace pressure gradients.

5. The method of claim 1 , wherein monitoring the optical emissions of the sub-nanoliter droplets is performed using a camera.

6. The method of claim 1 , wherein the at least one reporter is a fluorescent dye.

7. The method of claim 6 , where the reporter is resazurin or tetrazolium.

8. The method of claim 6 , wherein the monitoring the optical emissions of the sub-nanoliter droplets further comprises exciting the reporter using a light emitting diode (LED).

9. The method of claim 1 , wherein the incubating of the sub-nanoliter droplets is at a constant temperature.

10. The method of claim 9 , wherein the temperature is 37° C.

11. The method of claim 1 , wherein the microbes are bacteria.

12. The method of claim 11 , wherein the bacteria present in sub-nanoliter droplets are identified by gram-stain group based on the sub-nanoliter waveform.

13. The method of claim 1 wherein the sub-nanoliter droplet waveform is compared to a library of waveforms.

14. The method of claim 11 , wherein the bacteria present in sub-nanoliter droplets are identified by species, genus, family, or order based on the sub-nanoliter waveform.

Assignments (3)
CHANGE OF NAME Recorded Aug 20, 2020
From: KLARIS CORPORATION
To: PATTERN BIOSCIENCE, INC.
Reel/Frame 053560/0483 →
CHANGE OF NAME Recorded Jul 15, 2019
From: VIASPHERE, LLC,
To: KLARIS CORPORATION
Reel/Frame 049751/0194 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 22, 2017
From: ARAB, NICOLAS; JOHNSON, ROSS
To: VIASPHERE, LLC
Reel/Frame 042071/0729 →
Continuity (1)
Provisional Application 62407311 · Oct 12, 2016